Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary

Endocrinology

Volumn 152, Issue 7, 2011, Pages 2722-2730

  Recouvreux, M Victoria ^a   Guida, M Clara ^a   Rifkin, Daniel B ^b   Becu Villalobos, Damasia ^a   Díaz Torga, Graciela ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; ESTRADIOL; MESSENGER RNA; PROLACTIN; SULPIRIDE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; FEMALE; HYPOPHYSIS; HYPOPHYSIS CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HYPERPROLACTINEMIA; LACTOTROPHS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; PITUITARY GLAND, ANTERIOR; PROLACTIN; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE D2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79959474583     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1464     Document Type: Article

References (29)

1. Ben-Jonathan N 1985 Dopamine: a prolactin inhibiting hormone. Endocr Rev 6:564-589
2. Ben-Jonathan N, Hnasko R 2001 Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763 (Pubitemid 34214293)
3. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG 1998 Dopamine receptors: from structure to function. Physiol Rev 78:189-225 (Pubitemid 28070979)
4. Díaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly MA, Low MJ, Rubinstein M, Becú-Villalobos D 2002 Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 143:1270-1279 (Pubitemid 34274357)
5. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, Allen RG, Hnasko R, Ben-Jonathan N, Grandy DK, Low MJ 1997 Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19:103-113 (Pubitemid 27332997)
6. Cristina C, García-Tornadú I, Díaz-Torga G, Rubinstein M, Low MJ, Becú-Villalobos D 2006 The dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. Front Horm Res 35:50-63 (Pubitemid 44024241)
7. Yoshinaga K, Obata H, Jurukovski V, Mazzieri R, Chen Y, Zilberberg L, Huso D, Melamed J, Prijatelj P, Todorovic V, Dabovic B, Rifkin DB 2008 Perturbation of transforming growth factor (TGF)-β1 association with latent TGF-β binding protein yields inflammation and tumors. Proc Natil Acad Sci USA 105:18758-18763
8. Sarkar DK, Kim KH, Minami S 1992 Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825-1833
9. Sarkar DK, Pastorcic M, De A, Engel M, Moses H, Ghasemzadeh MB 1998 Role of transforming growth factor-b type I and TGF-b type II receptores in the TGF-b1 regulated gene expression in pituitary prolactin-secreting lactotropes. Endocrinology 139:3620-3628 (Pubitemid 28512322)
10. Sarkar DK, Chaturvedi K, Oomizu S, Boyadjieva NI, Chen CP 2005 Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-β1, and TGF-β type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology 146:4179-4188 (Pubitemid 41324010)
11. Sarkar DK, Boyadjieva NI 2007 Ethanol alters production and secretion of estrogen-regulated growth factors that control prolactin-secreting tumors in the pituitary. Alcohol Clin Exp Res 31:2101-2105 (Pubitemid 350150760)
12. De A, Morgan TE, Speth RC, Boyadjieva N, Sarkar DK 1996 Pituitary lactotrope expresses transforming growth factor b (TGF-b) type II receptor mRNA and protein and contains I-TGF-b1 binding sites. J Endocrinol 149:19-27
13. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK 1995 Reduction in the expression and action of transforming growth factor-b1 on lactotropes during estrogen-induced tumorigenesis. Cancer Res 55:4892-4898
14. Jin L, Tsumanuma I, Ruebel KH, Bayliss JM, Lloyd RV 2001 Analysis of homogeneous populations of anterior pituitary folliculostellate cells by laser capture microdissection and reverse transcription-polymerase chain reaction. Endocrinology 142:1703-1709 (Pubitemid 32405924)
15. Annes JP, Munger JS, Rifkin DB 2003 Making sense of latent TGFβ activation. J Cell Sci 116:217-224 (Pubitemid 36163863)
16. Annes JP, Chen Y, Munger JS, Rifkin DB 2004 Integrin αVβ6- mediated activation of latent TGF-β requires the latent TGF-β binding protein-1. J Cell Biol 165:723-734 (Pubitemid 38765773)
17. Asa SL, Kelly MA, Grandy DK, Low MJ 1999 Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140:5348-5355
18. Sarkar DK 2006 Genesis of prolactinomas: studies using estrogen-treated animals. Front Horm Res 35:32-49 (Pubitemid 44024240)
19. González Iglesias A, Díaz-Torga G, Piroli G, Achával-Zaia R, De Nicola AF, Libertun C, Becu-Villalobos D 2000 Bromocriptine restores Angiotensin II response in pituitary hyperplasia. Mol Cell Endocrinol 165:67-74 (Pubitemid 30625185)
20. Cristina C, Díaz-Torga G, Baldi A, Góngora A, Rubinstein M, Low MJ, Becú-Villalobos D 2005 Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice. Endocrinology 146:2952-2962 (Pubitemid 41002802)
21. Ben-Jonathan N 2005 Dopamine and transforming growth factor-β1: an odd couple in growth inhibition of the lactotrophs. Endocrinology 146:4177-4178 (Pubitemid 41324009)
22. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB 1997 Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int 51:1376-1382
23. Kochenour NK 1980 Lactation suppression. Clin Obstet Gynecol 23:1045-1059 (Pubitemid 11181720)
24. Llewellyn-Jones D 1968 Inhibition of lactation by oestrogens. Br Med J 4:387
25. Hentges S, Boyadjieva N, Sarkar DK 2000 Transforming growth factor-b3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141:859-867 (Pubitemid 32260428)
26. Spearow JL, Doemeny P, Sera R, Leffler R, Barkley M 1999 Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 285:1259-1261 (Pubitemid 29398611)
27. Paez-Pereda M, Kuchenbauer F, Arzt E, Stalla GK 2005 Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. Braz J Med Biol Res 38:1487-1494 (Pubitemid 41440220)
28. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE 1994 Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 269:26775-26782 (Pubitemid 24332871)
29. Sarkar AJ, Chaturvedi K, Chen CP, Sarkar DK 2007 Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors. J Endocrinol 192:395-403 (Pubitemid 46444441)